Using short columns to speed up LC–MS quantification in MS binding assays

Schnurr, 2007, vol. III, 577

Höfner, 2007, 247

de Jong, 2005, J. Chromatogr. B, 829, 1, 10.1016/j.jchromb.2005.10.002

Lundqvist, 2005, Curr. Opin. Drug Discov. Dev., 8, 513

Cooper, 2004, J. Mol. Recognit., 17, 286, 10.1002/jmr.675

Siegel, 2005, 27

Schermann, 2005, Expert Rev. Proteomics, 2, 475, 10.1586/14789450.2.4.475

de Boer, 2007, Trends Anal. Chem., 26, 867, 10.1016/j.trac.2007.08.004

Höfner, 2009, ChemMedChem, 4, 1523, 10.1002/cmdc.200900201

Hopfgartner, 2003, Mass Spectrom. Rev., 22, 195, 10.1002/mas.10050

Mann, 2007, LC–GC Eur., 20, 290

Jerkovich, 2007, 765

Zepperitz, 2006, ChemMedChem, 1, 208, 10.1002/cmdc.200500038

Dalby, 2003, Eur. J. Pharmacol., 479, 127, 10.1016/j.ejphar.2003.08.063

Meldrum, 1999, Epilepsia, 40, S2, 10.1111/j.1528-1157.1999.tb02087.x

Guidance for Industry, Bioanalytical Methods Validation, United States Food and Drug Administration, Washington, 2001.

Bylund, 2004, 1

Zweigenbaum, 2000, Anal. Chem., 72, 2446, 10.1021/ac991413p

Onorato, 2001, Anal. Chem., 73, 119, 10.1021/ac000845t

Heinig, 2003, J. Chromatogr. B, 795, 337, 10.1016/S1570-0232(03)00603-2

Yang, 2001, J. Chromatogr. A, 926, 43, 10.1016/S0021-9673(01)00963-3

Özbal, 2004, Assay Drug Dev. Technol., 2, 373, 10.1089/adt.2004.2.373

Livesay, 2008, Anal. Chem., 80, 294, 10.1021/ac701727r

Wickremsinhe, 2006, Curr. Drug Metabol., 7, 913, 10.2174/138920006779010610

Corr, 2006, J. Am. Soc. Mass Spectrom., 17, 1129, 10.1016/j.jasms.2006.04.026

Li, 2009, Anal. Chem., 81, 7724, 10.1021/ac901199w